25 Nervous System Signaling Chronic Pain Trends

‍Comprehensive data analysis of how pain neuroscience research is transforming the understanding and treatment of chronic pain

Chronic pain now affects one in four adults, and the numbers are climbing. Behind that statistic sits a growing body of research showing that persistent pain is not simply a tissue problem. Pain neuroscience increasingly points to the nervous system itself, where the brain and spinal cord can amplify, distort, or generate pain signals long after any original injury has healed. This shift in understanding is reshaping treatment approaches, moving from purely structural interventions toward methods that target pain signaling.

Key Takeaways

• Chronic pain is accelerating - Prevalence rose 19% between 2019 and 2023, now affecting an estimated 62.7 million US adults
• Central sensitization is measurable - Roughly half of patients with chronic spinal pain and over 60% of veterans with chronic pain show clinical evidence of nervous system amplification
• Brain-based treatments show durable results - PRT and EAET produce clinically significant pain reductions in randomized trials, with effects lasting 5 years
• Pain and mood share neural pathways - Nearly 40% experience depression or anxiety among adults with chronic pain, reflecting shared nervous system signaling
• The treatment landscape is shifting - Opioid dispensing rates fell sharply since 2012, while brain-based therapies are filling the gap with growing clinical evidence

Chronic Pain Prevalence: The Scale of a Growing Crisis

1. 24.3% of US adults reported chronic pain in 2023

The most recent National Health Interview Survey data confirms that 24.3% reported chronic pain among US adults in 2023, representing approximately 62.7 million people. Among those, 8.5% (about 22 million) reported high-impact chronic pain that frequently limits daily life and work activities.

These figures make chronic pain the most common reason adults seek medical care in the United States. Women (25.4%) are affected at slightly higher rates than men (23.2%), and prevalence increases with age, reaching 36.0% among adults 65 and older.

2. Chronic pain prevalence increased 19% in just four years

Between 2019 and 2023, prevalence rose to 24.3% from 20.4%, a 19% increase that has persisted beyond initial pandemic effects. This represents roughly 10 million more Americans living with chronic pain compared to four years earlier.

The sustained upward trend suggests structural factors at work, not just a temporary spike. Contributing elements may include delayed medical care during the pandemic, increased sedentary behavior, rising stress, and improved recognition of chronic pain conditions. For clinicians and health systems, the trajectory reinforces the urgency of scalable, evidence-based pain management approaches.

3. New chronic pain cases outpace diabetes, depression, and hypertension

Chronic pain develops at a rate of 52.4 cases per 1,000 people annually, a higher incidence rate than diabetes, depression, or high blood pressure. This means millions of people transition from acute or subacute pain to chronic pain every year.

The high incidence rate underscores the importance of early intervention. Research on nervous system signaling suggests that the longer pain persists, the more entrenched pain neural pathways become. Catching pain before the nervous system reorganizes around it may improve treatment outcomes.

4. The annual economic burden of chronic pain exceeds $725 billion

A 2024 expenditure analysis estimated the direct and indirect costs of chronic pain at more than $725 billion per year in the United States. When caregiver burden, disability benefits, and broader productivity losses are factored in, some estimates push the total above $1 trillion.

This figure exceeds the combined costs of cardiovascular disease, cancer, and injuries. The scale of the economic burden has driven growing interest in cost-effective, non-pharmacological interventions that address nervous system signaling rather than relying on repeated procedures or long-term medication management.

Central Sensitization Statistics: When the Nervous System Amplifies Pain

5. Nearly 50% of chronic spinal pain patients show measurable central sensitization

A prospective cohort study (2020-2023) found that 49.9% scored above threshold for central sensitization on the Central Sensitization Inventory (CSI ≥40) among patients with chronic spinal pain. Central sensitization occurs when the central nervous system enters a persistent state of heightened reactivity, amplifying incoming pain signals and lowering the threshold needed to trigger a pain response.

This is clinically significant because central sensitization responds differently to treatment than tissue-based pain. Standard structural interventions, such as injections or surgery, may not address the underlying neural amplification. Recognizing central sensitization helps clinicians match patients to treatments that target the nervous system rather than tissue pathology.

6. 62.5% of veterans with chronic pain meet central sensitization criteria

A veteran chronic pain study found an even higher rate: 62.5% met clinical criteria for central sensitization, with 23.9% in the severe range. The elevated prevalence likely reflects the combined impact of physical injury, psychological trauma, and prolonged stress on nervous system function.

The overlap between trauma history and central sensitization supports the understanding that emotional and psychological factors contribute directly to nervous system pain amplification. This is not pain being "in your head." It is measurable nervous system change driven by the interplay of physical and psychological experience.

7. Chronic pain patients show impaired descending pain inhibition, with a large effect size of 0.78

The body has a built-in pain regulation system, the descending inhibitory pathway, that normally dampens pain signals before they reach conscious awareness. A meta-analysis of 30 studies (778 patients, 664 controls) found that chronic pain patients show significantly reduced conditioned pain modulation compared to healthy adults.

This finding has been confirmed in subsequent research across low back pain, osteoarthritis, and fibromyalgia. When the body's natural braking system fails, normal sensations can be processed as painful, contributing to the persistence and spread of pain beyond the original injury site. The large effect size (0.78) indicates this is not a subtle difference but a pronounced impairment in how the nervous system regulates incoming signals.

Brain Neuroplasticity: How Chronic Pain Rewires Neural Circuits

8. Chronic pain is associated with 5-11% gray matter reduction, equivalent to 10-20 years of aging

Landmark neuroimaging research found that chronic back pain patients showed 5-11% gray matter loss compared to healthy controls, with gray matter decreasing by approximately 1.3 cubic centimeters for every year of chronic pain. The affected areas included the prefrontal cortex and thalamus, regions critical for decision-making, emotional regulation, and sensory processing.

While this study dates to 2004, its findings have been confirmed by later research, including a 2024 longitudinal study showing continued regional volume decreases in the thalamus, anterior cingulate cortex, and amygdala of chronic pain patients. The critical insight is that these brain changes appear to be consequence rather than cause, which means they may be addressable through treatment.

9. Brain activity shifts from sensory to emotional circuits as pain becomes chronic

Longitudinal fMRI research tracking patients as their back pain transitioned from acute to chronic found that pain shifted to emotions at the neural circuit level. In the acute phase, pain activated the insula, thalamus, and anterior cingulate cortex. As pain chronified over 12 months, activity migrated to the medial prefrontal cortex and amygdala.

This shift shows chronic pain becoming, at a neural level, less of a sensory event and more of an emotional and learned state. It provides a neurobiological basis for why approaches targeting fear, emotional processing, and cognitive reappraisal can reduce chronic pain even when the original tissue has fully healed.

10. Chronic pain alters multiple brain regions, and these changes reverse with effective treatment

A 2025 neuroplasticity review found that chronic pain is associated with widespread structural changes across limbic, prefrontal, and cingulate circuits. These regions govern emotional regulation, decision-making, and sensory processing, and show measurable gray matter alterations in chronic pain populations.

The most significant aspect of this research is reversibility. Multiple studies show that effective treatment can restore brain anatomy and connectivity patterns toward normal baselines. The brain's plasticity works in both directions: the same neural mechanisms that established the pain can, with targeted intervention, help resolve it. This supports the scientific rationale for brain-based treatment approaches.

The Pain-Mood-Sleep Connection: Shared Nervous System Pathways

11. 39.3% of chronic pain patients have depression and 40.2% have anxiety

The largest global meta-analysis on pain and mood, covering 376 studies and 347,468 adults, found pooled rates of 39.3% for depression and 40.2% for anxiety among people with chronic pain. Among fibromyalgia patients specifically, rates reached 54% for depression and 55.5% for anxiety.

These comorbidity rates are roughly three times higher than in the general population. The overlap is not coincidental: pain, mood, and stress share overlapping neural circuits in the prefrontal cortex, anterior cingulate, amygdala, and insula, the same regions implicated in central sensitization and chronification.

12. 12 million US adults experience co-occurring chronic pain with anxiety or depression

Population-level data show that approximately 12 million US adults (4.9% of the adult population) live with co-occurring chronic pain and clinically significant anxiety or depression symptoms. Among adults with chronic pain, 23.9% have unremitted mood symptoms, rising to 39.5% among those with high-impact chronic pain.

This co-occurrence suggests shared nervous system mechanisms rather than two separate conditions happening to coexist. Treatment approaches that address both pain signaling and emotional processing simultaneously, rather than treating each in isolation, may be better aligned with how the nervous system actually operates.

13. 50-88% of people with chronic pain report significant sleep disruption

Between 50% and 88% experience ongoing sleep difficulties among individuals with chronic pain, with prevalence reaching 95% in fibromyalgia populations. The relationship runs in both directions: poor sleep lowers pain thresholds through changes in central nervous system processing, and pain itself fragments sleep architecture.

Sleep disruption directly impacts the nervous system's ability to regulate pain. Fragmented sleep reduces descending inhibitory pathway function, increases proinflammatory signaling, and heightens the brain's sensitivity to incoming sensory input. Breaking the pain-sleep cycle is one reason multimodal approaches that address nervous system regulation broadly tend to produce better outcomes than targeting pain in isolation.

14. Activated glial cells in the brain and spinal cord maintain chronic pain through neuroinflammation

PET imaging research has identified elevated neuroinflammatory markers in key brain regions of chronic pain patients, including the thalamus, insula, and somatosensory cortices. The source: activated microglia and astrocytes that release proinflammatory cytokines (TNF-alpha, IL-1-beta, IL-6), directly sensitizing nearby neurons and sustaining heightened pain signaling.

This neuroinflammation represents a distinct nervous system pathway for maintaining chronic pain. Unlike peripheral tissue inflammation that may respond to standard anti-inflammatory medications, neuroinflammation occurs within the central nervous system itself. This helps explain why over-the-counter anti-inflammatories often provide limited relief for chronic pain conditions driven by central nervous system processes.

Fear, Catastrophizing, and Reappraisal: The Psychology of Pain Amplification

15. 50-70% of chronic pain patients experience clinically significant fear of movement

Kinesiophobia, the fear of movement or reinjury, affects an estimated 50-70% of pain patients. Prevalence reaches as high as 79% among patients with musculoskeletal pain, with men reporting higher rates than women across studies.

Fear of movement is not irrational in context. The nervous system has learned to associate movement with danger, even when the original injury has healed. This learned protective response becomes self-reinforcing: avoidance leads to deconditioning, deconditioning increases pain sensitivity, and increased pain reinforces the fear. Breaking this cycle requires interventions that address the nervous system's threat appraisal, not just physical rehabilitation.

16. Psychological factors explain 58% of the variance in disability outcomes

Research in adults with chronic low back pain found that a model including psychological factors explained 58% of the variance in disability outcomes. Pain catastrophizing emerged as a significant independent predictor (beta = 0.18) alongside pain intensity (beta = 0.60), depression, and anxiety. Catastrophizing involves rumination about pain, magnification of its threat, and feelings of helplessness.

This is not about blaming patients for their experience. Catastrophizing reflects measurable nervous system patterns: heightened activation in pain-processing brain regions, reduced prefrontal cortex engagement, and increased connectivity between the amygdala and sensory cortex. These neural signatures respond to targeted behavioral interventions, which is why addressing the psychological dimension of pain can produce measurable improvements in physical function.

17. Reattributing pain to mind-brain processes mediates recovery in chronic back pain

A PRT secondary analysis found that the degree to which patients shifted their understanding of pain from a purely structural cause to a brain-generated signal mediated their pain outcomes. Participants with the greatest shift in pain attribution showed the largest pain reductions.

This connects nervous system science directly to clinical practice. When patients with chronic back pain understand that their pain reflects nervous system amplification rather than ongoing tissue damage, the reappraisal itself appears to change how the brain processes pain signals. It is not simply psychological comfort but a mechanism by which the nervous system recalibrates its threat assessment.

Brain-Based Treatment Outcomes: Evidence for Nervous System Retraining

18. 66% of PRT participants became pain-free or nearly pain-free after a 4-week intervention

In a randomized controlled trial of 151 adults who had lived with chronic back pain for an average of 10 years, 66% became pain-free or nearly pain-free at post-treatment. This compared to 20% for placebo and 10% for usual care. The effect size (Hedges' g = -1.14 vs. placebo) was described as "very rarely observed in chronic pain treatment trials."

PRT works by helping patients reappraise their pain as a brain-generated false alarm rather than evidence of tissue damage. The treatment consists of just 9 sessions over 4 weeks, making it one of the shortest evidence-based psychological interventions for chronic pain. Lin Health's approach is based on this research.

19. 55% of PRT participants remained pain-free at 5-year follow-up, with no booster sessions

The 5-year PRT follow-up found that more than half of participants maintained their pain-free or nearly pain-free status, with no additional treatment sessions between the original intervention and follow-up. This compares to 20% for placebo and 10% for usual care at the same time point.

Five-year durability without boosters is exceptional for any chronic pain intervention. The sustained benefit suggests that PRT does not merely manage symptoms but may produce lasting changes in how the nervous system processes pain signals. This is consistent with the neuroplasticity research showing that brain changes in chronic pain are reversible with effective treatment.

20. EAET achieved 63% clinically significant pain reduction compared to 17% for CBT

A 2024 trial comparing Emotional Awareness and Expression Therapy to Cognitive Behavioral Therapy in 126 older veterans with chronic musculoskeletal pain found that 63% achieved pain reduction at clinically significant levels (30% or greater), compared to 17% for CBT. At 6-month follow-up, 41% of EAET participants maintained their improvement versus 14% for CBT.

EAET works by directly addressing the emotional underpinnings of chronic pain, helping patients process anger, grief, guilt, and other emotions that may be activating the nervous system's threat-detection circuits. The trial also showed greater mood improvements in the EAET group, reinforcing the shared nervous system pathways between pain and emotional distress.

21. CBT produces consistent, small-to-moderate pain reductions across chronic pain populations

A Cochrane meta-analysis found that Cognitive Behavioral Therapy for chronic pain produces a standardized mean difference of -0.09 for pain versus active controls, a small but statistically significant effect. CBT's benefits extend beyond pain reduction to include improvements in disability, mood, and catastrophizing, with effects persisting at 6- to 12-month follow-up.

CBT remains the most-studied psychological intervention for chronic pain, with the broadest evidence base across conditions. Its consistent, replicable effects across diverse populations make it a behavioral pain care foundation. Newer therapies like PRT and EAET show larger effects in head-to-head comparisons, but CBT's decades of evidence and adaptability keep it central to multimodal treatment approaches.

22. Mindfulness-based stress reduction shows moderate effect sizes for pain intensity

A 2025 network meta-analysis found that MBSR produced a standardized mean difference of -0.76 for pain intensity, indicating a moderate effect size and placing it among the more effective mind-body interventions for chronic pain. MBSR was also the top-performing mindfulness-based intervention for concurrent depression improvement.

The dual benefit for pain and mood aligns with the nervous system signaling picture: mindfulness practices appear to down-regulate the brain's threat-detection systems while strengthening prefrontal regulatory control. For patients with co-occurring pain and mood symptoms (a group comprising nearly 40% of chronic pain patients), MBSR addresses both through shared neural mechanisms.

23. Pain neuroscience education combined with exercise enhances treatment outcomes

A 2025 umbrella review synthesizing multiple meta-analyses found that pain neuroscience education combined with physiotherapy or exercise (4 studies, 860 participants) produced enhanced pain reduction compared to either intervention alone. PNE combined with broader biopsychosocial interventions (10 studies, 3,220 participants) showed even more sustained improvements.

PNE teaches patients how the nervous system processes and amplifies pain, helping them understand why their pain persists despite tissue healing. When paired with graded exercise or behavioral therapy, this understanding appears to prime the nervous system for more effective retraining. The combination effect suggests that education itself functions as a nervous system intervention, changing how the brain interprets movement and sensation.

The Shifting Treatment Landscape

24. Opioid dispensing rates have fallen sharply since their 2012 peak

Opioid dispensing rates fell from 46.8 prescriptions per 100 persons in 2019 to 35.4 per 100 persons in 2024, continuing a sustained decline from their 2012 peak. AMA analyses of CDC prescription data indicate that total opioid prescriptions dropped from approximately 260 million in 2012 to roughly 126 million in 2024.

This sustained decline reflects both regulatory pressure and growing clinical recognition that opioids are poorly suited for long-term chronic pain management. The gap in the treatment landscape has created demand for evidence-based alternatives that target the nervous system mechanisms underlying chronic pain, rather than masking symptoms pharmacologically.

25. Pain neuroscience education reduces catastrophizing and fear of movement

A 2025 umbrella review synthesizing multiple meta-analyses confirmed that PNE produces measurable reductions in both pain catastrophizing and kinesiophobia when delivered as part of multimodal care. These reductions in fear and catastrophizing, both key nervous system amplifiers of pain, help explain why PNE-informed treatment programs show broader benefits than exercise or education alone.

This finding closes a loop in the nervous system signaling story. When patients understand the mechanisms behind their pain, their brains process threat signals differently. Education becomes, in a neuroscience sense, a form of nervous system retraining that primes patients for complementary behavioral interventions like graded exposure, somatic tracking, and emotional processing techniques.

How Lin Health Helps with Chronic Pain

The statistics in this article point to a consistent finding: chronic pain is a nervous system signaling condition that responds to treatments targeting the brain and nervous system, not just the body's tissues. Lin Health's program is built on this principle.

Lin Health's approach is based on findings from research on PRT, CBT, ACT, and EAET, the same evidence-based therapies highlighted throughout this article. The program pairs trained recovery coaches with patients for weekly live sessions, supplemented by between-session chat support and a structured app with learning and practice materials. The focus is on nervous system retraining through fear reduction, emotional processing, and cognitive reappraisal.

What makes Lin Health different from general therapy or self-guided programs:

• Specialized in physical conditions. Unlike general-purpose therapists, Lin Health coaches are trained specifically in pain neuroscience and nervous system retraining.
• Insurance covered. The program is covered by most major insurance plans, with high-coverage availability in Colorado, Texas, Florida, California, and New York.
• Short wait times. Most patients receive a same-day callback after signing up, with rapid access to their first physician consultation.
• Coach-led, not self-paced. Weekly sessions with a dedicated recovery coach provide accountability and personalized guidance that self-directed apps and books cannot match.

Lin Health treats chronic pain conditions including lower back pain, neck pain, fibromyalgia, shoulder pain, and arthritis, as well as persistent symptom conditions like chronic migraine and IBS.

If you have been living with chronic pain and standard treatments have not provided lasting relief, a nervous-system-based approach may be worth exploring. Lin Health is fully covered by insurance for most patients, with no out-of-pocket cost. Explore Lin Health coverage.

Frequently Asked Questions

What is nervous system signaling in chronic pain?

Nervous system signaling in chronic pain refers to how the brain and spinal cord process, amplify, or generate pain signals. In many chronic pain conditions, the nervous system continues to produce pain responses after the original injury has healed. This can involve central sensitization, impaired descending pain modulation, and shifts in brain activity from sensory to emotional circuits.

How does central sensitization contribute to chronic pain?

Central sensitization occurs when the central nervous system enters a state of heightened reactivity, amplifying incoming signals and lowering the threshold for triggering pain. Research shows it is present in roughly half of chronic spinal pain patients. It helps explain why pain can persist, spread, and intensify without new tissue damage.

Can brain changes from chronic pain be reversed?

Evidence suggests they can. A 2025 neuroplasticity review found that brain structural changes associated with chronic pain, including widespread gray matter alterations across limbic and prefrontal circuits, can reverse with effective treatment. Brain-based interventions like PRT have shown durable pain reductions lasting at least 5 years.

What is the difference between acute and chronic pain at the nervous system level?

Acute pain is a normal danger signal processed through sensory circuits in the insula, thalamus, and anterior cingulate cortex. As pain becomes chronic, activity shifts to emotions in the medial prefrontal cortex and amygdala. Chronic pain also involves central sensitization and impaired descending inhibition, changes not present in acute pain.

What are brain-based treatments for chronic pain?

Brain-based treatments include Pain Reprocessing Therapy (PRT), Emotional Awareness and Expression Therapy (EAET), Cognitive Behavioral Therapy (CBT), mindfulness-based stress reduction (MBSR), and pain neuroscience education (PNE). These approaches target nervous system mechanisms that maintain chronic pain rather than focusing on tissue-level pathology.

Does stress make chronic pain worse through the nervous system?

Stress activates the same neural circuits involved in pain processing, including the amygdala, anterior cingulate cortex, and prefrontal cortex. Prolonged stress contributes to central sensitization, impairs descending pain modulation, and activates neuroinflammatory pathways through glial cell activation. This is why co-occurring anxiety and depression are found in nearly 40% of chronic pain patients.

This article is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before making any changes to your pain management plan.